Vote: Floor vote
NY SenateMay 29, 2026Result: passed
(58) (0) (0) (5)
Senate bill · S6758 (2025-26)
Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic
Latest action May 29, 2026
New York State Senate
Same as A9010, the matching bill in the Assembly.
Summary
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Summary from NY Open Legislation. How we handle summaries
Amends the Public Health Law.
From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Oct 20, 2026. About our data
Following needs an Agora account. You will sign in first, then come back to this page.
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Purpose, from the sponsor's memo
Amends the public health law to better protect the health and safety of patients undergoing opioid prescription dosage for treatment as well as inform patients of the side-effects that may result from such use.
Filed with the bill. Read it on nysenate.gov (opens in a new tab)
Where it stands
Passed one of the two chambers; it still needs the other.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
Health · New York State Assembly
Also referred to Health · New York State Senate.
Cosponsors
Christopher Ryan, Emily Gallagher and 9 more on Agora
Showing the cosponsors who are on Agora, A to Z. The official record may list more.
Read on NY Senate (opens in a new tab)- Democratic9
- Republican2
This bill has cosponsors from more than one party.
Shown in neutral colors by design; Agora is non-partisan.
The sponsor's argument
Why Nathalia Fernandez says this is needed
When patients are given opioid prescriptions for pain relief, they are often uninformed of the risks and side-effects associated with the use of aforesaid medications, such as physical and psychological dependen- cies and misuse. Moreover, providers frequently neglect providing infor- mation of alternative prescriptions available to them, or why the prescription is necessary to their well-being. This legislation will help in preventing patients from being left in the dark regarding the risk management, side effects, alternative methods, and imperatives of their prescribed medication.
This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.
Recorded votes
Vote: Committee vote · Health
Senate HealthMay 12, 2026Result: passed
(14) (0) (0) (1)
Full history
- May 29, 2026
Sent to the executive
DELIVERED TO ASSEMBLY
NY Senate
- May 29, 2026
Passed a chamber
PASSED SENATE
NY Senate
- May 29, 2026
Referred to committee
REFERRED TO HEALTH
NY Assembly
- May 14, 2026
Advanced to Third Reading
ADVANCED TO THIRD READING
NY Senate
- May 13, 2026
2ND Report CAL.
2ND REPORT CAL.
NY Senate
Show full history (9 earlier events)Show less history
- May 12, 2026
1ST Report CAL.1095
1ST REPORT CAL.1095
NY Senate
- May 5, 2026
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Senate
- May 4, 2026
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Assembly
- Jan 22, 2026
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Assembly
- Jan 16, 2026
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Senate
- Jan 7, 2026
Referred to committee
REFERRED TO HEALTH
NY Senate
- Jan 7, 2026
Referred to committee
REFERRED TO HEALTH
NY Assembly
- Aug 13, 2025
Referred to committee
REFERRED TO HEALTH
NY Assembly
- Mar 24, 2025
Referred to committee
REFERRED TO HEALTH
NY Senate